TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0nMAssay Description:Among the compounds of the Examples 1-1 to 1-61, compounds that showed excellent inhibitory activity (inhibitory activity of 85% or more at 20 μ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.0700nMAssay Description:The mTOR kinase TR-FRET assay utilizes a physiologically relevant protein substrate for mTOR (4E-BP1, labeled with an acceptor fluorophore (Green Flu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.0800nMpH: 7.4 T: 2°CAssay Description:The enzyme was assayed in DELFIA format using purified FLAG-TOR in kinase buffer containing ATP and His6-S6K in the presence of inhibitor compounds. ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of mTOR kinase expressed in human HEK293 cells by western blot analysisMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of mTOR in HEK293 cellsMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human mTOR (1360-2549 amino acids) expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.110nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.130nMAssay Description:Inhibition of recombinant FLAG-tagged mTOR (1362 to 2549) (unknown origin) expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.150nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.160nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.170nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.180nMAssay Description:Competitive inhibition of human mTOR using 4EBP1 as substrate in presence of [33gammaP]-ATP after 120 mins by filter binding methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.190nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of mTOR assessed as inhibition of phosphorylation of 4EBP1 by Lantha-Screen enzyme assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of mTOR in HEK293 cells by DELFIA assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human mTOR (1360-2549 amino acids) expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of mTOR (unknown origin) using GFP-4E-BP1 as substrate after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:The mTOR kinase TR-FRET assay utilizes a physiologically relevant protein substrate for mTOR (4E-BP1, labeled with an acceptor fluorophore (Green Flu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:The enzyme was assayed in DELFIA format using purified FLAG-TOR in kinase buffer containing ATP and His6-S6K in the presence of inhibitor compounds. ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human Flag-tagged mTOR expressed in HEK293 cells after 2 hrs by DELFIAMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.210nMAssay Description:The mTOR kinase TR-FRET assay utilizes a physiologically relevant protein substrate for mTOR (4E-BP1, labeled with an acceptor fluorophore (Green Flu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.220nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.220nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.230nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.230nMAssay Description:Inhibition of Flag-tagged human mTOR by DELFIA methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.25nMAssay Description:Inhibition of mTOR (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Medicinal Bioconvergence Research Center
US Patent
Medicinal Bioconvergence Research Center
US Patent
Affinity DataIC50: 0.25nMAssay Description:The mTOR kinase TR-FRET assay utilizes a physiologically relevant protein substrate for mTOR (4E-BP1, labeled with an acceptor fluorophore (Green Flu...More data for this Ligand-Target Pair